The global veterinary artificial insemination market size was estimated at USD 7.37 billion in 2023 and is projected to grow at a CAGR of 6.34% from 2024 to 2030. Growing demand to improve animal efficiency and productivity, consumption of meat, milk, & dairy products, need for sustainable food production, supportive initiatives by industry stakeholders, and adoption of sexed semen are some of the key drivers of this market. In January 2024, the National Dairy Development Board the owner of the Mother Dairy brand in India, imported 40,000 doses of bull semen from Brazil to boost milk production via artificial insemination of Indian native breeds such as Gir, and Kankrej.
The COVID-19 pandemic presented several challenges for the market. This included challenges in performing AI procedures on-site, dampened demand for AI products and services, risks, and uncertainty due to fluctuating consumption patterns across several key markets. However, the pandemic, along with other break-out diseases during the period such as the African Swine Fever (ASF), highlighted the need to produce superior livestock to secure the food source. To safeguard employees and farmers against COVID-19, in June 2020, the Animal Husbandry Department of India launched a program. Under this program, the department offered telephonic assistance to animal farm owners. In addition, artificial insemination services were being delivered to farmers at their doorstep during the lockdown period. Such supportive initiatives have contributed to the market growth.
The increasing adoption of artificial insemination services is a key market driver. Veterinary AI service providers offer expertise in performing AI procedures for various animal species, including cattle, horses, pigs, dogs, cats, and others. These professionals are skilled in semen collection, processing, and insemination techniques, ensuring the proper timing and accurate placement of semen to optimize conception rates. Artificial insemination service providers often offer comprehensive reproductive management programs that encompass the entire breeding process. This may include estrus synchronization, reproductive health assessment, fertility testing, ultrasound examinations, and artificial insemination. They help animal owners and breeders optimize reproductive performance, maximize conception rates, and minimize the risk of reproductive disorders.
The market exhibits a low market concentration, indicating a diverse landscape with numerous players involved in semen production, processing & distribution, insemination equipment manufacturing, and service provision. This diversity fosters competition and innovation, offering consumers a wide range of choices and driving continuous improvement in products and services.
In terms of growth stage, the market is positioned at a medium level, characterized by steady but substantial expansion. Factors such as increasing demand for superior livestock genetics, advancements in reproductive technologies, and rising awareness about the benefits of artificial insemination contribute to this moderate growth trajectory. While the market is not in its infancy, there remains ample room for further development and penetration into new markets and segments.
The pace of market growth is accelerating, spurred by various factors including technological advancements, government support, and evolving customer preferences. This rapid expansion is evident in the increasing adoption of artificial insemination techniques by farmers, the proliferation of specialized equipment and services, and the continual innovation aimed at improving breeding outcomes and efficiency. As demand for high-quality genetics and sustainable livestock production continues to rise, the market is poised for further acceleration in the coming years.
The market demonstrates a moderate degree of innovation, characterized by ongoing technological advancements, collaboration between market players, and supportive initiatives. For instance, in October 2022, Genus extended its partnership with Tropic - an Agri-biotech company to apply the latter’s Gene Editing, Gene Silencing (GEiGS) technology in bovine and swine genetics. The market sees a steady stream of improvements aimed at optimizing reproductive processes, enhancing genetic diversity, and addressing emerging challenges in animal breeding.
Within the market, there exists a moderate level of mergers and acquisitions activity, indicative of ongoing consolidation and strategic partnerships among industry players. These transactions are often driven by the desire to expand market reach, access new technologies or expertise, and achieve economies of scale. In October 2018, for instance, Koepon Holding BV and Cooperative Resources International (CRI) merged to form URUS Group- a leading provider of livestock artificial insemination genetics and farm management information.
The market experiences a moderate impact of regulations, with governmental oversight primarily focused on ensuring the safety, efficacy, and ethical use of reproductive technologies. While regulations exist to safeguard animal welfare and genetic diversity, they generally allow for flexibility in business operations and innovation within the industry. Compliance with regulatory standards is important for market participants, but the regulatory environment is not overly restrictive, allowing for the adoption of new technologies and practices that contribute to market growth and advancement.
While alternative reproductive technologies exist, such as natural mating or embryo transfer, artificial insemination offers distinct benefits, including precise genetic selection, disease control, and increased breeding efficiency. Furthermore, the comprehensive nature of artificial insemination services, which often include genetic counseling, semen analysis, and reproductive management, further distinguishes them from alternative options. As a result, artificial insemination products & services maintain a unique position within the market, with limited viable substitutes offering comparable expertise and results.
In March 2023, URUS launched Dairy Genetics Multiplication Program in African countries such as Kenya, Uganda, and Tanzania. This is expected to fuel AI adoption by small scale producers, build dependable network of AI technicians, and develop partnerships with local stakeholders. Similar initiatives by key market players leads to a high level of regional expansion activities in the market.
Based on solutions, the services segment led the market with the largest revenue share of 42.05% in 2023. These include AI service execution, reproduction management, semen evaluation & analysis, genetic consultations, and training & education. On the other hand, the semen segment is anticipated to grow at the fastest CAGR of 6.98% over the forecast period.
The semen segment is further bifurcated into normal or conventional semen and sexed semen. The normal semen accounted for the largest revenue share in 2023, while the sexed semen is projected to grow at the fastest CAGR during the forecast period. This is due to the increasing adoption of sexed semen and supportive government policies. In June 2021, the Indian government partnered with Genus ABS to subsidize the price of sexed semen straws. This helped bring down the price of sexed semen from USD 18 to USD 1 thus supporting dairy farmers in the Indian state of Maharashtra.
Based on animal type, the bovine segment held the market with the largest revenue share of 40.52% in 2023. The swine segment is estimated to grow at the fastest CAGR of 6.81% during the forecast period. This is owing to widespread adoption of AI in cattle and pig breeding across key markets, initiatives by key companies, increasing advancements in bovine and swine genetics, and the need to produce sustainable animals.
For instance, a company in Denmark- DanBred offers superior bovine genetics through DanBred AI. It also offers the GenePro solution for tracking the semen and genetic progress of the herd for better accountability and ROI. In August 2023, Urus Group- a leading market player in the genetics sector acquired Leachman Cattle of Colorado. This is expected to elevate URUS into a leadership role in the beef sector across North America and the globe.
Based on distribution channel, the private segment led the market with the largest revenue share of 64.13% in 2023 and is also projected to grow at the fastest CAGR over the forecast period.This is due to a growing network of private companies and organizations involved in the distribution and supply of artificial insemination products and services to veterinary clinics, breeders, and livestock owners. These entities play a crucial role in making AI technology and genetic materials accessible to end-users.
The public segment also held a notable share of the market in 2023. Initiatives by publicly managed semen collection or distribution centers and veterinary facilities, such as government veterinary clinics or hospitals contribute to the segment share. These facilities may offer AI services to farmers, livestock owners, and pet owners at subsidized rates or as part of government-sponsored animal health programs. National Dairy Development Board in India for instance, is a statutory body of the Indian government that offers AI solutions to farmers in the country.
North America dominated the veterinary artificial insemination market with the revenue share of 30.28% in 2023. This is owing to the well-equipped animal husbandry industry, growing awareness and adoption of AI for breeding livestock, and the presence of key companies such as ST genetics. The company is U.S.-based and one of the leading players in the sexed semen market. The Sex Sorted Semen produced by the company offers an average of 93.0% female purity for various breeds of cattle and buffaloes.
The veterinary artificial insemination market in the U.S. attributed to the largest share by country in North America in 2023. This market is driven by factors such as a strong infrastructure, significant investments in research and development, the growing trend of precision breeding, and the increasing adoption of genomic selection methods. As per the National Association of Animal Breeders about 69 million units of bovine semen were sold in the U.S. via domestic sales, export sales, custom collection, and imported units combined.
The veterinary artificial insemination market in Europe is characterized by a robust infrastructure, advanced technological capabilities, and a strong emphasis on animal welfare and breeding standards. Semen production and distribution are well-established, with a wide range of genetic resources available for various livestock species. Insemination equipment and services are also highly developed, with a focus on precision breeding techniques and the use of advanced reproductive technologies contributing to the market growth.
The UK veterinary artificial insemination market attributed to the second largest share by country in Europe in 2023. While artificial insemination is widely practiced, there is a growing emphasis on ethical and sustainable breeding practices, with a focus on minimizing the potential negative impacts on animals and the environment. The growing number of market participants is another key driver for the market growth. For example, in August 2020, Cogent and AB Europe partnered to launch sexed semen services for ovine farmers in the UK
The veterinary artificial insemination market in Asia Pacific is witnessing rapid growth, driven by factors such as increasing demand for high-quality livestock genetics, rising awareness about the benefits of AI in animal breeding, and government initiatives to modernize the agricultural sector. Semen production and distribution networks are expanding to meet the growing demand from farmers, particularly in countries with large livestock populations such as China and India. Insemination equipment and services are also evolving, with a focus on affordability, accessibility, and customized solutions tailored to local breeding practices and environmental conditions.
The veterinary artificial insemination market in India is expected to grow at the fastest CAGR from 2024 to 2030. This is fueled by increasing demand for improved livestock productivity, supportive government initiatives, high population of cattle, and rising awareness among end users. Semen production and distribution networks are expanding to cater to the diverse needs of farmers across different regions and livestock species thus fueling the market growth.
The veterinary artificial insemination market in Latin America is anticipated to grow at the fastest CAGR of 7.07% from 2024 to 2030. Large cattle inventory, a thriving dairy industry, supportive government initiatives, and growing awareness about the benefits of artificially inseminating livestock are propelling the market growth. Various Latin American nations have put in place government initiatives and programs to support animal breeding, genetic advancement, and disease prevention, creating an ideal atmosphere for the market growth.
The Argentina veterinary artificial insemination market is projected to grow at the notable CAGR from 2024 to 2030. As per the Argentine Chamber of Biotechnology of Reproduction and Artificial Insemination, an estimated 8.2 million doses of bovine semen were sold in the country in 2023. Amongst these, about 4.7 million were attributed to the beef sector while 3.5 million were accounted for by the dairy sector. Increasing demand for animal protein is anticipated to propel the market growth in the near future.
The veterinary artificial insemination market in the Middle East & Africa region is characterized by a growing demand for improved livestock genetics, driven by factors such as population growth, urbanization, and changing dietary preferences. Semen production and distribution networks are developing, albeit at a slower pace compared to other regions, with a focus on enhancing genetic diversity and resilience in local livestock breeds. Insemination equipment and services are gradually gaining traction, supported by government initiatives to modernize the agricultural sector and improve food security.
The South Africa veterinary artificial insemination market attributed to the largest share by country in Middle East & Africa region in 2023. This is due to increasing demand for improved livestock genetics, advancements in reproductive technologies, and a growing focus on enhancing agricultural productivity. In May 2021, for instance, Sexing Technologies partnered with RAMSEM in South Africa to establish a semen sorting lab to produce fresh and frozen sex-sorted semen from cattle, sheep, and goats.
The market is characterized by intense competition and is fragmented in nature. Several large, medium, and small players are implementing strategic initiatives to boost their market share. Genus for instance is a major player in the animal genetics industry. It offers a wide range of reproductive solutions, including AI services and products for dairy and beef cattle as well as swine.
Key players vie for market share through innovative product offerings, technological advancements, and superior service provision. Companies engage in continuous research and development to enhance semen quality, optimize insemination processes, and cater to diverse animal breeding needs. In addition, competition intensifies as providers strive to offer comprehensive solutions, including training programs, genetic counseling, and reproductive health monitoring. Pricing strategies, distribution networks, and customer relationships also play crucial roles in shaping competitive dynamics within this specialized sector, where efficiency, reliability, and customer satisfaction are paramount.
The following are the leading companies in the veterinary artificial insemination market. These companies collectively hold the largest market share and dictate industry trends.
In February 2024, HKScan Sweden partnered with PIC to develop its Hampshire pig breed by gaining access to PIC’s expertise and cutting-edge technology
In January 2023, BullWise- a breeding organization in Ireland and CRV partnered to distribute CRV genetic solutions in Ireland & Northern Ireland, offering farmers access to quality semen from top bulls. With this, BullWIse became a key distributor for CRV in the region
In March 2022, Hypor BV collaborated with Zemspol Dešná- a leading pork producer in the Czech Republic. With this, Zemspol Dešná became Hypor BV’s nucleus farm partner to supply swine genetics to countries in Eastern and Central Europe
In June 2021, Genus- a key market player partnered with World Wide Sires Deutschland GmbH to serve Luxembourg, Austria, and Germany regions jointly as a distribution partner of ABS under the name World Wide Sires Deutschland
Report Attribute |
Details |
Market size value in 2024 |
USD 7.78 billion |
Revenue forecast in 2030 |
USD 11.25 billion |
Growth rate |
CAGR of 6.34% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Report updated |
April 2024 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Solutions, animal type, distribution channel, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Genus; URUS Group LP; CRV; SEMEX; IMV Technologies; Select Sires Inc.; Swine Genetics International; Shipley Swine Genetics; Stallion AI Services Ltd; STgenetics |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global veterinary artificial insemination market report based on solutions, animal type, distribution channel, and region:
Solutions Outlook (Revenue, USD Million, 2018 - 2030)
Equipment & Consumables
Semen
Normal
Sexed
Services
Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Bovine
Swine
Ovine & Caprine
Equine
Other Animals
Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Private
Public
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Norway
Sweden
Denmark
Asia Pacific
Japan
India
China
South Korea
Thailand
Australia
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
b. The global veterinary artificial insemination market size was estimated at USD 7.37 billion in 2023 and is expected to reach USD 7.78 billion in 2024.
b. The global veterinary artificial insemination market is expected to grow at a compound annual growth rate of 6.34% from 2024 to 2030 to reach USD 11.25 billion by 2030.
b. North America dominated the veterinary artificial insemination market with a share of about 30% in 2023. This is owing to the well-equipped animal husbandry industry, growing awareness and adoption of AI for breeding livestock, and the presence of key companies such as STgenetics.
b. Some key players operating in the veterinary artificial insemination market include Genus, URUS Group LP, CRV, SEMEX, IMV Technologies, Select Sires Inc., Swine Genetics International, Shipley Swine Genetics, Stallion AI Services Ltd, and STgenetics.
b. Growing demand to improve animal efficiency and productivity, consumption of meat, dairy, & diary products, need for sustainable food production, supportive initiatives by industry stakeholders, and adoption of sexed semen are some of the key drivers of this market.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."